Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PF-02545920 in Acute Exacerbation of Schizophrenia
NCT00570063Phase 2Terminated
- Sponsor
- Pfizer
- Start
- Nov 2007
- Primary completion
- Feb 2008
- Countries
- 1
01
Overview
A Phase 2 trial of mardepodect in schizophrenia, sponsored by Pfizer. Started Nov 2007; status: terminated.
02
Drugs
mardepodect
03
Conditions
schizophrenia
Beyond the preview
Go deeper on NCT00570063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00570063.